PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 137 filers reported holding PDL BIOPHARMA INC in Q2 2020. The put-call ratio across all filers is 0.31 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $223,000 | +10.4% | 70,799 | 0.0% | 0.00% | – |
| Q2 2020 | $202,000 | -1.9% | 70,799 | -3.2% | 0.00% | – |
| Q1 2020 | $206,000 | -8.0% | 73,141 | +5.8% | 0.00% | – |
| Q4 2019 | $224,000 | +34.9% | 69,132 | -8.4% | 0.00% | – |
| Q3 2019 | $166,000 | -33.1% | 75,500 | -4.4% | 0.00% | – |
| Q2 2019 | $248,000 | -29.7% | 78,943 | -16.7% | 0.00% | – |
| Q1 2019 | $353,000 | +18.5% | 94,763 | -7.9% | 0.00% | – |
| Q4 2018 | $298,000 | +11.2% | 102,865 | +0.8% | 0.00% | – |
| Q3 2018 | $268,000 | -2.2% | 102,023 | -12.8% | 0.00% | – |
| Q2 2018 | $274,000 | -24.1% | 116,950 | -4.8% | 0.00% | – |
| Q1 2018 | $361,000 | +11.1% | 122,879 | +3.9% | 0.00% | – |
| Q4 2017 | $325,000 | -23.0% | 118,241 | -5.2% | 0.00% | -100.0% |
| Q3 2017 | $422,000 | +30.7% | 124,788 | -4.7% | 0.00% | – |
| Q2 2017 | $323,000 | +5.6% | 130,908 | -3.0% | 0.00% | – |
| Q1 2017 | $306,000 | +21.9% | 134,929 | +13.9% | 0.00% | – |
| Q4 2016 | $251,000 | -34.8% | 118,480 | +3.3% | 0.00% | -100.0% |
| Q3 2016 | $385,000 | +7.8% | 114,711 | +0.9% | 0.00% | 0.0% |
| Q2 2016 | $357,000 | +4.4% | 113,643 | +5.3% | 0.00% | – |
| Q1 2016 | $342,000 | -8.8% | 107,904 | +1.9% | 0.00% | – |
| Q4 2015 | $375,000 | -29.1% | 105,903 | +0.8% | 0.00% | -100.0% |
| Q3 2015 | $529,000 | -18.9% | 105,040 | +3.6% | 0.00% | 0.0% |
| Q2 2015 | $652,000 | -12.0% | 101,366 | -3.8% | 0.00% | 0.0% |
| Q1 2015 | $741,000 | -5.7% | 105,383 | +3.4% | 0.00% | 0.0% |
| Q4 2014 | $786,000 | +2.1% | 101,887 | -1.0% | 0.00% | 0.0% |
| Q3 2014 | $770,000 | -21.1% | 102,965 | +2.1% | 0.00% | 0.0% |
| Q2 2014 | $976,000 | +11.4% | 100,842 | -4.3% | 0.00% | 0.0% |
| Q1 2014 | $876,000 | -2.3% | 105,348 | -0.8% | 0.00% | 0.0% |
| Q4 2013 | $897,000 | +15.6% | 106,248 | +9.0% | 0.00% | 0.0% |
| Q3 2013 | $776,000 | +3.3% | 97,451 | +0.2% | 0.00% | 0.0% |
| Q2 2013 | $751,000 | – | 97,301 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SMH CAPITAL ADVISORS INC | 81,713 | $176,000 | 0.39% |
| BRANDES INVESTMENT PARTNERS, LP | 5,465,156 | $11,805,000 | 0.30% |
| Crestline Management, LP | 875,000 | $1,890,000 | 0.30% |
| West Family Investments, Inc. | 539,450 | $1,165,000 | 0.29% |
| WEBER ALAN W | 200,000 | $432,000,000 | 0.19% |
| Zebra Capital Management LLC | 73,910 | $160,000 | 0.18% |
| RBF Capital, LLC | 569,323 | $1,230,000 | 0.14% |
| Leap Investments LP | 69,496 | $150,000 | 0.08% |
| Connor, Clark & Lunn Investment Management Ltd. | 4,387,038 | $9,476,000 | 0.06% |
| CHICAGO EQUITY PARTNERS LLC | 519,315 | $1,122,000 | 0.05% |